Nonetheless, these findings suggest that both POU2AF2 and POU2AF3 are capable of transcriptionally activating the majority of 11q23.1 trans-eQTL gene targets, likely through genomic binding with POU2F3, in SCLC-P cell lines. The gene discussed is POU2AF3; the disease is small cell lung carcinoma.